BiotechTube

Haemate HS

Phase 2Withdrawn
0 watching 0 views this week⚡ Active
51
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Blood Loss, Surgical

Conditions

Blood Loss, Surgical

Trial Timeline

Jan 1, 2008 → Jul 1, 2011

NCT ID
NCT00618293

About Haemate HS

Haemate HS is a phase 2 stage product being developed by CSL for Blood Loss, Surgical. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00618293. Target conditions include Blood Loss, Surgical.

Hype Score Breakdown

Clinical
17
Activity
12
Company
9
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00618293Phase 2Withdrawn

Competing Products

20 competing products in Blood Loss, Surgical

See all competitors
ProductCompanyStageHype Score
micafungin + voriconazoleAstellas PharmaApproved
85
CefiderocolShionogiPhase 2
52
Bunazosin + Doxazosin + ValsartinEisaiApproved
85
PegfilgrastimKyowa KirinPhase 2
52
epoetin alfaJohnson & JohnsonPhase 2/3
65
epoetin alfaJohnson & JohnsonPhase 2/3
65
epoetin alfaJohnson & JohnsonPhase 2
52
Metoprolol Succinate + HydrochlorothiazideAstraZenecaPhase 3
77
AZD6140 + PlaceboAstraZenecaPhase 1
33
NKTR-118 + moxifloxacin + PlaceboAstraZenecaPhase 1
33
MEDI-551AstraZenecaPhase 1
33
Ecallantide + Cyklokapron(R)MerckPhase 2
52
DaptomycinMerckPhase 2
52
ecallantide + placeboMerckPhase 2
52
MK0859MerckPhase 1
33
Ecallantide + PlaceboMerckPhase 2
52
HSC835NovartisPhase 2
52
AliskirenNovartisApproved
85
Aliskiren and HCTZNovartisApproved
85
Aliskiren + Amlodipine + Placebo Aliskiren + Placebo AmlodipineNovartisPhase 2
52

Other Products from CSL

IgPro10Approved
84
four factor prothrombin complex concentrateApproved
84
Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP)Approved
84
IgPro10Approved
84
Blood coagulation Factor VIII and vWF, humanApproved
84